Figure 1.

Kaplan–Meier estimates of PFS and OS in all patients and according to eligibility for clinical trial. (A) PFS and OS in all patients; the median was 3.5 months (gray line) and 6.7 months (black line), respectively. (B) PFS according to eligibility; the median was 1.1 months in arm ineligible (gray line) and 4.5 months in arm eligible (black line). (C) OS according to eligibility; the median was 2.9 months in arm ineligible (gray line) and 10.5 months in arm eligible (black line).

Abbreviations: PFS, progression-free survival; OS, overall survival.